Axl-RTK Inhibition Modulates Monocyte Immune Response to Enhance the Anti-Tumor Effects of CD19 Redirected Chimeric Antigen Receptor T Cells in Preclinical Models
Year: 2020
Type: article
Source: Blood
Authors: Reona Sakemura, Michelle J. Cox, Elizabeth L. Siegler, Erin E. Tapper, Wendy K. Nevala, Mehrdad Hefazi, Claudia Manriquez Roman, Kendall J. Schick, Ismail Can, Evandro D. Bezerra, Lionel Kankeu Fonkoua, Paulina Horvei, Michael W. Ruff, Lars Mouritsen, Jason M. Foulks, Steven L. Warner, Wei Ding, Susan L. Slager, Sameer A. Parikh, Neil E. Kay, Saad S. Kenderian
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3094847416